Looking Forward to a GREAT 2020, page-12

We have turned over more than 1/3 of the BOT register since the 23rd Oct. We are now well into the holding pattern awaiting news.

IMO, we will see a run of announcements to rebuild the share price value. We will see an announcement (maybe more than one) regarding the Antimicrobial studies, we'll see the Atopic Derma results (which should be positive if they are anything like Acne without the stuff up), we'll see some presentations for the upcoming conferences that BOT will be attending (we know from the past that they put valuable info in these), and more info regarding the recruitment/commencement of the Rosacea trials, more details about the Acne FDA meeting.

The first half of 2020 will be full of announcements, hence why I believe that now is the time to stock up. Let's not forget that these guys have made it pretty clear that they want to partner with big pharma... if that's going to happen, I suspect this will be the year. Two products out or coming out of phase 2 studies and heading into (Acne) or potentially heading into (Atopic Derma) phase 3 studies plus the additional products commencing trials / studies.

Let's not forget that the products BOT are trialling / studying are EACH sold in multi-billion dollar markets!

With a market cap just over $80m and a share price in the low 8's this is a solid punt. (IMO, DYoR).

Conferences:
JP Morgan Healthcare Jan 13-16
https://www.jpmorgan.com/global/healthcare-conference

Dermatology Summit - Jan 12
http://www.dermsummit.com/2020/

Dermatology Innovation Forum - Mar 19
http://www.dermsummit.com/2020/